Adult children can start by reporting specific daily changes and asking for a medication review. They can also give written permission to share information and ask about next evaluation steps. Parkinson's disease dementia means thinking changes in a person with Parkinson's that interfere with daily life.
The Michael J. Fox Foundation says attention, executive function and visuospatial skills are most often affected, rather than memory. Examples include following group conversations, multitasking, problem-solving and judging distances while driving.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What details help the doctor most?
- What will the evaluation involve?
- How to raise hallucinations and drug questions?
- How to keep future care choices clear?
What details help the doctor most?
Mild cognitive impairment means thinking changes beyond normal aging that do not block daily tasks. The Michael J. Fox Foundation reports about 25% of people with Parkinson's experience it.
It may stay stable, improve, or progress to dementia over years. Bring short, concrete notes rather than general worry. Focus on daily function, safety, and change over time.
- What changed and when it started
- Which daily tasks now need help
- Driving, work, money, or medication errors
- Sleep, mood, hallucinations, or new confusion
- Full medication and supplement list
What will the evaluation involve?
The Parkinson's Foundation advises adult children to tell the doctor about cognitive concerns directly. Expect a medication review and possible referral to a neurologist or neuropsychologist. Occupational therapy can teach coping strategies, and speech therapy can help with language problems.
There is no single test for Parkinson's disease dementia, according to the Parkinson's Foundation in its cognitive changes guide. Clinicians review history, symptoms, medications, and daily function. They often use brief screens such as MMSE or MoCA to assess impairment.
How to raise hallucinations and drug questions?
Report new, frightening, or disruptive hallucinations or delusions promptly. The Michael J. Fox Foundation notes Parkinson's medications can contribute to these symptoms in its thinking and memory guide. Ask whether a dose change, cause check, or treatment change is needed. The Michael J.
Fox Foundation states pimavanserin is the only FDA-approved drug for Parkinson's hallucinations and delusions, including with dementia. Ask what benefits and side effects to watch for in your parent. The Alzheimer's Association lists rivastigmine as approved for mild-to-moderate dementia associated with Parkinson's disease. It notes no treatment stops the underlying brain-cell damage. Care focuses on symptom relief, with close physician collaboration on drug choice and dose.
How to keep future care choices clear?
Cognitive screens and drug responses vary by person. Ask what a score change means for safety, work, and daily help. Ask when to repeat testing or adjust support.
The National Institute on Aging recommends early advance-care planning in its advance-care planning tips for caregivers. Give doctors written permission to speak with caregivers. File copies of health-care directives in all medical records before capacity declines.





